Subcellular reorganization and altered phosphorylation of the astrocytic gap junction protein connexin43 in human and experimental temporal lobe epilepsy

Glia. 2017 Nov;65(11):1809-1820. doi: 10.1002/glia.23196. Epub 2017 Aug 10.

Abstract

Dysfunctional astrocytes are increasingly recognized as key players in the development and progression of mesial temporal lobe epilepsy (MTLE). One of the dramatic changes astrocytes undergo in MTLE with hippocampal sclerosis (HS) is loss of gap junction coupling. To further elucidate molecular mechanism(s) underlying this alteration, we assessed expression, cellular localization and phosphorylation status of astrocytic gap junction proteins in human and experimental MTLE-HS. In addition to conventional confocal analysis of immunohistochemical staining we employed expansion microscopy, which allowed visualization of blood-brain-barrier (BBB) associated cellular elements at a sub-µm scale. Western Blot analysis showed that plasma membrane expression of connexin43 (Cx43) and Cx30 were not significantly different in hippocampal specimens with and without sclerosis. However, we observed a pronounced subcellular redistribution of Cx43 toward perivascular endfeet in HS, an effect that was accompanied by increased plaque size. Furthermore, in HS Cx43 was characterized by enhanced C-terminal phosphorylation of sites affecting channel permeability. Prominent albumin immunoreactivity was found in the perivascular space of HS tissue, indicating that BBB damage and consequential albumin extravasation was involved in Cx43 dysregulation. Together, our results suggest that subcellular reorganization and/or abnormal posttranslational processing rather than transcriptional downregulation of astrocytic gap junction proteins account for the loss of coupling reported in human and experimental TLE. The observations of the present study provide new insights into pathological alterations of astrocytes in HS, which may aid in the identification of novel therapeutic targets and development of alternative anti-epileptogenic strategies.

Keywords: albumin extravasation; astrocyte; astrocytic endfeet; hippocampal sclerosis; temporal lobe epilepsy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens / metabolism
  • Astrocytes / pathology
  • Astrocytes / ultrastructure*
  • Cell Membrane / metabolism
  • Cell Membrane / ultrastructure
  • Connexin 30 / metabolism
  • Connexin 43 / genetics
  • Connexin 43 / metabolism*
  • Disease Models, Animal
  • Epilepsy, Temporal Lobe / chemically induced
  • Epilepsy, Temporal Lobe / pathology*
  • Excitatory Amino Acid Agonists / toxicity
  • Female
  • Glial Fibrillary Acidic Protein / metabolism
  • Hippocampus / pathology*
  • Humans
  • Kainic Acid / toxicity
  • Male
  • Mice
  • Mice, Transgenic
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • Proteoglycans / metabolism
  • S100 Calcium Binding Protein beta Subunit / metabolism
  • Subcellular Fractions / metabolism*
  • Up-Regulation / physiology*

Substances

  • Antigens
  • Connexin 30
  • Connexin 43
  • Excitatory Amino Acid Agonists
  • GJB6 protein, human
  • Glial Fibrillary Acidic Protein
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Proteoglycans
  • S100 Calcium Binding Protein beta Subunit
  • chondroitin sulfate proteoglycan 4
  • Kainic Acid